4.5 Article

Gain of function SCN1A disease-causing variants: Expanding the phenotypic spectrum and functional studies guiding the choice of effective antiseizure medication

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

SCN1A gain-of-function mutation causing an early onset epileptic encephalopathy

Jerome Clatot et al.

Summary: Loss-of-function variants in SCN1A cause Dravet syndrome, while gain-of-function variants lead to separate entities of SCN1A-related disorders. A recurrent p.R1636Q gain-of-function variant has been identified in four individuals with early onset DEE, characterized by focal tonic seizures. Electrophysiological analysis revealed mixed gain-of-function effects with abnormal sodium channel properties, partially corrected by oxcarbazepine.

EPILEPSIA (2023)

Article Clinical Neurology

SCN1A overexpression, associated with a genomic region marked by a risk variant for a common epilepsy, raises seizure susceptibility

Katri Silvennoinen et al.

Summary: Mesial temporal lobe epilepsy with hippocampal sclerosis and a history of febrile seizures is associated with common variation at rs7587026, located in the promoter region of SCN1A. This study explores the underlying mechanisms and found that individuals with the minor allele at rs7587026 showed increased SCN1A expression. In addition, reduced hippocampal volume and increased seizure activity were observed in zebrafish larvae with overexpressed scn1a.

ACTA NEUROPATHOLOGICA (2022)

Article Clinical Neurology

ILAE classification and definition of epilepsy syndromes with onset in neonates and infants: Position statement by the ILAE Task Force on Nosology and Definitions

Sameer M. Zuberi et al.

Summary: This article proposes a classification and definition of epilepsy syndromes in neonates and infants, aiming to support epilepsy diagnosis and emphasize the importance of classifying epilepsy by syndrome and etiology. The article reports the epidemiology, clinical course, seizure types, EEG, neuroimaging, genetics, and differential diagnosis for each syndrome, and presents self-limited syndromes, developmental and epileptic encephalopathies, and etiology-specific epilepsy syndromes.

EPILEPSIA (2022)

Article Clinical Neurology

The gain of function SCN1A disorder spectrum: novel epilepsy phenotypes and therapeutic implications

Andreas Brunklaus et al.

Summary: This study describes different phenotypes of SCN1A-related epilepsy, some of which are associated with febrile seizures and familial hemiplegic migraine. The research found that these phenotypes are caused by SCN1A variants, and by conducting clinical, genetic, and functional evaluations of the affected individuals, it reveals the potential efficacy of sodium channel blockers in treating this disease.

BRAIN (2022)

Article Clinical Neurology

Whole exome sequencing and co-expression analysis identify an SCN1A variant that modifies pathogenicity in a family with genetic epilepsy and febrile seizures plus

Michael F. Hammer et al.

Summary: The study found that the second variant in the SCN1A gene, L375S, may counteract the loss-of-function effect of K1372E, preventing individuals carrying both alleles from exhibiting epilepsy-related symptoms.

EPILEPSIA (2022)

Article Genetics & Heredity

De novo mutations of SCN1A are responsible for arthrogryposis broadening the SCN1A-related phenotypes

Dana Jaber et al.

Summary: We report pathogenic heterozygous missense de novo variants in SCN1A in three unrelated individuals with AMC. These variants are newly occurring, demonstrating the critical role of SCN1A in prenatal motor development. Lack of motor denervation in affected individuals suggests that AMC is caused by brain involvement.

JOURNAL OF MEDICAL GENETICS (2021)

Review Neurosciences

Sodium channelopathies in neurodevelopmental disorders

Miriam H. Meisler et al.

Summary: This review explores the neurological disorders associated with mutations in SCN1A, SCN2A, and SCN8A genes and the therapeutic opportunities arising from recent mechanistic insights. It summarizes the basic elements of sodium channel function used to characterize patient variants and provides examples of the effects of patient mutations on channel function. The review also highlights emerging therapeutic interventions based on new insights into mechanisms of sodium channelopathies.

NATURE REVIEWS NEUROSCIENCE (2021)

Review Physiology

SODIUM CHANNELOPATHIES OF SKELETAL MUSCLE AND BRAIN

Massimo Mantegazza et al.

Summary: Voltage-gated sodium channels play a crucial role in various electrically excitable cells, and mutations in them lead to a wide range of diseases. Mutations affecting periodic paralysis in skeletal muscle were first discovered, providing a foundation for understanding related conditions in the brain.

PHYSIOLOGICAL REVIEWS (2021)

Article Multidisciplinary Sciences

Spreading depression as an innate antiseizure mechanism

Isra Tamim et al.

Summary: The study demonstrates a reciprocal relationship between spreading depression and seizures in an animal model, showing that seizures trigger spreading depression, which then terminates the seizure and prevents its generalization.

NATURE COMMUNICATIONS (2021)

Article Biochemical Research Methods

Modeling NaV1.1/SCN1A sodium channel mutations in a microcircuit with realistic ion concentration dynamics suggests differential GABAergic mechanisms leading to hyperexcitability in epilepsy and hemiplegic migraine

Louisiane Lemaire et al.

Summary: Loss of function mutations of SCN1A cause epilepsy while gain of function mutations cause hemiplegic migraine, with distinct effects on ion fluxes and susceptibility to depolarization block in interconnected GABAergic and glutamatergic neurons. The study suggests different mechanisms of network hyperexcitability for migraine and epileptogenic Na(V)1.1 mutations beyond changes in firing frequency.

PLOS COMPUTATIONAL BIOLOGY (2021)

Article Medicine, Research & Experimental

Initiation of migraine-related cortical spreading depolarization by hyperactivity of GABAergic neurons and NaV1.1 channels

Oana Chever et al.

Summary: Spreading depolarizations (SDs) are involved in various neurological conditions, with GABAergic interneurons playing a key role in the initiation of cortical spreading depression (CSD). The study found that hyperactivity of GABAergic interneurons can ignite CSD in the neocortex without the need for GABA or glutamatergic synaptic transmission. This neocortex-specific mechanism of CSD initiation is relevant to familial hemiplegic migraine type-3 (FHM3) caused by gain-of-function mutations of Na(V)1.1.

JOURNAL OF CLINICAL INVESTIGATION (2021)

Article Multidisciplinary Sciences

A Study among the Genotype, Functional Alternations, and Phenotype of 9 SCN1A Mutations in Epilepsy Patients

Daniela Kluckova et al.

SCIENTIFIC REPORTS (2020)

Article Clinical Neurology

SCN1A gain of function in early infantile encephalopathy

Geza Berecki et al.

ANNALS OF NEUROLOGY (2019)

Letter Clinical Neurology

Early infantile SCN1A epileptic encephalopathy: Expanding the genotype-phenotype correlations

Carlotta Spagnoli et al.

SEIZURE-EUROPEAN JOURNAL OF EPILEPSY (2019)

Editorial Material Clinical Neurology

Beyond Dravet Syndrome: Characterization of a Novel, More Severe SCN1A-Linked Epileptic Encephalopathy

Veronica C. Beck et al.

EPILEPSY CURRENTS (2019)

Article Neurosciences

A two-hit story: Seizures and genetic mutation interaction sets phenotype severity in SCN1A epilepsies

Ana Rita Salgueiro-Pereira et al.

NEUROBIOLOGY OF DISEASE (2019)

Article Medicine, General & Internal

Dravet Syndrome in Lebanon: First Report on Cases with SCN1A Mutations

Saada Alame et al.

CASE REPORTS IN MEDICINE (2019)

Review Neurosciences

Post-translational dysfunctions in channelopathies of the nervous system

Benedetta Terragni et al.

NEUROPHARMACOLOGY (2018)

Review Neurosciences

Pathophysiological mechanisms of migraine and epilepsy: Similarities and differences

Massimo Mantegazza et al.

NEUROSCIENCE LETTERS (2018)

Article Neurosciences

Gain of Function for the SCN1A/hNav1.1-L1670W Mutation Responsible for Familial Hemiplegic Migraine

Sandra Dhifallah et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2018)

Article Genetics & Heredity

Contribution of next generation sequencing in pediatric practice in Lebanon. A Study on 213 cases

Pratibha Nair et al.

MOLECULAR GENETICS & GENOMIC MEDICINE (2018)

Article Clinical Neurology

Targeted next generation sequencing: the diagnostic value in early-onset epileptic encephalopathy

Sarenur Gokben et al.

ACTA NEUROLOGICA BELGICA (2017)

Article Clinical Neurology

Not all SCN1A epileptic encephalopathies are Dravet syndrome

Lynette G. Sadleir et al.

NEUROLOGY (2017)

Article Clinical Neurology

Genetic epilepsy with febrile seizures plus Refining the spectrum

Yue-Hua Zhang et al.

NEUROLOGY (2017)

Article Clinical Neurology

Diagnostic Yield From 339 Epilepsy Patients Screened on a Clinical Gene Panel

Kameryn M. Butler et al.

PEDIATRIC NEUROLOGY (2017)

Article Multidisciplinary Sciences

Voltage-gated sodium channels assemble and gate as dimers

Jerome Clatot et al.

NATURE COMMUNICATIONS (2017)

Article Multidisciplinary Sciences

Nonfunctional NaV1.1 familial hemiplegic migraine mutant transformed into gain of function by partial rescue of folding defects

Sandrine Cestele et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)

Article Clinical Neurology

De novo SCN1A mutations in migrating partial seizures of infancy

D. Carranza Rojo et al.

NEUROLOGY (2011)

Article Clinical Neurology

Genetic testing in the epilepsies-Report of the ILAE Genetics Commission

Ruth Ottman et al.

EPILEPSIA (2010)

Review Clinical Neurology

Sodium channel SCN1A and epilepsy: Mutations and mechanisms

Andrew Escayg et al.

EPILEPSIA (2010)

Article Pharmacology & Pharmacy

Na+channelopathies and epilepsy: recent advances and new perspectives

Carla Marini et al.

Expert Review of Clinical Pharmacology (2010)

Article Neurosciences

A Functional Null Mutation of SCN1B in a Patient with Dravet Syndrome

Gustavo A. Patino et al.

JOURNAL OF NEUROSCIENCE (2009)

Review Neurosciences

How do mutant Nav1.1 sodium channels cause epilepsy?

David S. Ragsdale

BRAIN RESEARCH REVIEWS (2008)

Article Clinical Neurology

The spectrum of SCNIA-related infantile epileptic encephalopathies

Louise A. Harkin et al.

BRAIN (2007)

Article Clinical Neurology

Nonfunctional SCN1A is common in severe myoclonic epilepsy of infancy

Iori Ohmori et al.

EPILEPSIA (2006)

Article Multidisciplinary Sciences

Identification of an Nav1.1 sodium channel (SCN1A) loss-of-function mutation associated with familial simple febrile seizures

M Mantegazza et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Neurosciences

Molecular determinants for modulation of persistent sodium current by G-protein βγsubunits

M Mantegazza et al.

JOURNAL OF NEUROSCIENCE (2005)

Article Multidisciplinary Sciences

Noninactivating voltage-gated sodium channels in severe myoclonic epilepsy of infancy

TH Rhodes et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)